Analysis of Specialty Nephrology Care Among Patients With Chronic Kidney Disease and High Risk of Disease Progression

被引:10
作者
Wang, Maggie [1 ]
Peter, Samson S. [2 ]
Chu, Chi D. [3 ,4 ]
Tuot, Delphine S. [3 ,4 ,5 ]
Chen, Jonathan H. [6 ,7 ]
机构
[1] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Div Nephrol, Priscilla Chan & Mark Zuckerberg San Francisco Ge, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Ctr Innovat Access & Qual, San Francisco, CA 94143 USA
[6] Stanford Univ, Stanford Ctr Biomed Informat Res, 3180 Porter Dr,Room B132, Stanford, CA 94305 USA
[7] Stanford Univ, Dept Med, Div Hosp Med, 3180 Porter Dr,Room B132, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
GLOMERULAR-FILTRATION-RATE; ALBUMINURIA; MORTALITY; FAILURE;
D O I
10.1001/jamanetworkopen.2022.25797
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Identification of patients with chronic kidney disease (CKD) with high risk of progression to kidney failure can help ensure they receive appropriate and effective nephrology care. OBJECTIVE To examine whether patients with CKD at various levels of kidney failure risk receive nephrology care within 1 year of established risk. DESIGN, SETTING, AND PARTICIPANTS This population-based, retrospective cohort study collected nationwide administrative health claims data from 156 733 adult patients who met the Kidney Disease: Improving Global Outcomes initiative CKD diagnostic criteria between January 1, 2012, and December 31, 2019, and had an available urine albumin to creatinine ratio within 90 days of a serum creatinine laboratory test. Patients with a history of dialysis or kidney transplant, a prior visit with a nephrologist in the past year, or palliative care billing codes or those who died or disenrolled within 1 year of the albumin to creatinine ratio measurement were excluded. Data analysis was performed from September 10, 2022, to February 14, 2022. EXPOSURES Kidney failure risk computed with the 5-year Kidney Failure Risk Equation. MAIN OUTCOMES AND MEASURES The main outcome was nephrology care rates across tiers of kidney failure risk, estimated as the proportion of individuals having a nephrologist visit within 1 year after index time. RESULTS The study population consisted of 156 733 patients with CKD (mean [SD] age, 74.6 [8.4] years; 91906 [58.6%] female; 86 457 [55.2%] White). A total of 106 004 patients (67.6%) had a low (<= 1%) 5-year risk of kidney failure. Nephrology visit rates increased with higher kidney failure risk. Among the 137 highest-risk patients, 79 (57.7%; 95% CI, 48.4%-64.7%) had a nephrology visit. Among 7730 patients with risk above a 10% threshold, 3208 (41.5%; 95% CI, 40.3%-42.4%) had a nephrology visit. CONCLUSIONS AND RELEVANCE This study's findings suggest that nearly half of patients with CKD at high risk of progressing to kidney failure do not have a nephrologist visit within 1 year of established risk. These findings have implications in the design of risk-based guidelines for referral and in the practice of delivering nephrology care to patients with CKD.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Chronic kidney disease referral practices among non-nephrology specialists: A single-centre experience
    Buttigieg, Jesmar
    Mercieca, Liam
    Saliba, Arielle
    Aquilina, Simon
    Farrugia, Emanuel
    Fava, Stephen
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 29 : 93 - 97
  • [22] Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent
    Briasoulis, Alexandrios
    Bakris, George L.
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (03)
  • [23] Biochemistry markers in detection and risk staging of chronic kidney disease progression
    Perez Aguilar, Rossana Cristina
    Veronica Oldano, Ana
    Noemi Avila, Mariela
    Lucas Luciardi, Hector
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2020, 54 (04): : 383 - 393
  • [24] Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)
    Yuan, Jun
    Zou, Xin-Rong
    Han, Si-Ping
    Cheng, Hong
    Wang, Lan
    Wang, Jin-Wei
    Zhang, Lu-Xia
    Zhao, Ming-Hui
    Wang, Xiao-Qin
    BMC NEPHROLOGY, 2017, 18
  • [25] Hospitalization Risk among Older Adults with Chronic Kidney Disease
    Wong, Eugenia
    Ballew, Shoshana H.
    Daya, Natalie
    Ishigami, Junichi
    Rebholz, Casey M.
    Matsushita, Kunihiro
    Grams, Morgan E.
    Coresh, Josef
    AMERICAN JOURNAL OF NEPHROLOGY, 2019, 50 (03) : 212 - 220
  • [26] Timing of referral of chronic kidney disease patients to nephrology services (adult)
    Luxton, Grant
    NEPHROLOGY, 2010, 15 : S2 - S11
  • [27] The primary care physician: nephrology interface for the identification and treatment of chronic kidney disease
    Stevens, Paul E.
    Farmer, Christopher K.
    Hallan, Stein I.
    JOURNAL OF NEPHROLOGY, 2010, 23 (01) : 23 - 32
  • [28] Predictive factors of rapid linear renal progression and mortality in patients with chronic kidney disease
    Ali, Ibrahim
    Chinnadurai, Rajkumar
    Ibrahim, Sara T.
    Green, Darren
    Kalra, Philip A.
    BMC NEPHROLOGY, 2020, 21 (01)
  • [29] Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study
    Guessous, Idris
    McClellan, William
    Vupputuri, Suma
    Wasse, Haimanot
    BMC NEPHROLOGY, 2009, 10
  • [30] Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease
    Min, Hyang Ki
    Sung, Su Ah
    Chung, Wookyung
    Kim, Yeong Hoon
    Chae, Dong-Wan
    Ahn, Curie
    Oh, Kook-Hwan
    Park, Sue K.
    Lee, Sung Woo
    KIDNEY & BLOOD PRESSURE RESEARCH, 2021, 46 (04) : 460 - 468